Latest drug discovery Stories
Phase 3-ready AGB101 designed to address aMCI, the pre-dementia stage of Alzheimer's Disease BALTIMORE, Jan.
Dramatically improving opportunities for patients to find the right clinical trial MOUNTAIN VIEW, California, January 27, 2015 /PRNewswire/ -- U.S.-based cancer
WEST HAVEN, Conn., Jan. 23, 2015 /PRNewswire/ -- NanoViricides, Inc.
LONDON and BOSTON, January 23, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted
DALLAS, January 23, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced
Selexis SA Is the First Biotechnology Company to Deliver Manufacturing-Ready Research Cell Banks with a Fully Sequenced Genome and Transcriptome Geneva, Switzerland
DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance
LONDON and BOSTON, January 22, 2015 /PRNewswire/ -- Stable Receptor, X-ray Structure and Hit Series Generated for PAR2, a Previously
Lifescienceindustryresearch.com adds "Global Cancer Biomarkers Market 2015-2019" a new industry research report in its store.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.